Completed PHASE2 INTERVENTIONAL NCT00000241

Flupenthixol Decanoate in Methamphetamine Smoking - 1

Flupenthixol Decanoate in Methamphetamine Smoking

Sponsor: Friends Research Institute, Inc.

Updated 5 times since 2017 Last updated: Jan 11, 2017 Started: Feb 28, 1994 Completion: May 31, 1996

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Substance-Related Disorders, this trial is completed. The trial is conducted by Friends Research Institute, Inc. and has accumulated 5 data snapshots since 1994. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States